1 |
intravitreal triamcinolone acetonide
(247 times)
|
Ophthalmology (197 times)
|
IOP (59 times) BCVA (53 times) DME (41 times)
|
2003 Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
|
2 |
intravitreal triamcinolone
(43 times)
|
Ophthalmology (37 times)
|
BCVA (14 times) PDT (10 times) VA (9 times)
|
2004 Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study.
|
3 |
intravitreal TA
(4 times)
|
Ophthalmology (3 times)
|
TA (3 times) IOP (2 times) BCVA (1 time)
|
2007 Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
|
4 |
intravitreal injection of TA
(3 times)
|
Ophthalmology (2 times)
|
TA (3 times) AMD (1 time) BCVA (1 time)
|
2010 Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
|
5 |
intravitreal TA injection
(2 times)
|
Ophthalmology (1 time)
|
TA (2 times) IOP (1 time) PPV (1 time)
|
2006 Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
|
6 |
IVTA group
(2 times)
|
Ophthalmology (2 times)
|
AV (1 time) BRVO (1 time) CSME (1 time)
|
2006 Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
|
7 |
injection of preserved triamcinolone acetonide
(1 time)
|
Ophthalmology (1 time)
|
---
|
2008 Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.
|
8 |
injection, foveal thickness was more decreased in the triamcinolone acetonide
(1 time)
|
Ophthalmology (1 time)
|
DME (1 time) IL (1 time) IP (1 time)
|
2011 Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
|
9 |
intravenous total anesthesia
(1 time)
|
Anesthesiology (1 time)
|
---
|
1994 [Total intravenous anesthesia in general surgery].
|
10 |
intravenous tranexamic acid
(1 time)
|
Bone Diseases (1 time)
|
OR (1 time) OTA (1 time)
|
2013 Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures.
|